Premium
Smith and Nephew Plc (SN.)
LSE
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-03 | Mr. Mizanu KebedeChief Quality & Regulatory Affairs Officer | 22,19 | 0,00 | Achat | - | 442,00 | 5,29% |
| 2026-06-03 | Mr. Paul ConnollyPresident of Global Operations | 52,01 | 0,00 | Achat | - | 499,00 | 11,64% |
| 2026-06-03 | Dr. Deepak S. NathCEO & Director | 52,17 | 0,00 | Achat | - | 5,11k | 1,03% |
| 2026-06-03 | Mr. Scott SchaffnerPresident of Sports Medicine | 57,57 | 0,00 | Achat | - | 1,70k | 3,51% |
| 2026-05-05 | Cevian Capital ABSociété | 9,58M | 143,66M | Achat | 14,61 - 15,58 | 101,05M | 10,48% |
| 2026-05-27 | Mr. John Terence RogersCFO & Executive Director | 61,90 | 945,87 | Acquisition Under Employee Benefit Plan | 15,28 | 77,22k | 0,08% |
| 2026-05-27 | Mr. Scott SchaffnerPresident of Sports Medicine | 2,15k | 32,83k | Acquisition Under Employee Benefit Plan | 15,28 | 73,41k | 3,01% |
| 2026-05-27 | Dr. Deepak S. NathCEO & Director | 6,26k | 95,65k | Acquisition Under Employee Benefit Plan | 15,28 | 414,72k | 1,53% |
| 2026-05-27 | Mr. Paul ConnollyPresident of Global Operations | 1,19k | 18,18k | Acquisition Under Employee Benefit Plan | 15,28 | 38,00k | 3,23% |
| 2026-05-27 | Ms. Alison ParkesCCO & Compliance APAC | 153,59 | 2,35k | Acquisition Under Employee Benefit Plan | 15,28 | 1,41k | 12,22% |
| 2026-03-17 | Cevian Capital ABSociété | 9,77M | 158,64M | Achat | 15,44 - 17,06 | 91,46M | 11,97% |
| 2026-04-15 | Mr. Craig GaffinPresident of Global Orthopaedics | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Mr. Mizanu KebedeChief Quality & Regulatory Affairs Officer | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Mr. Paul ConnollyPresident of Global Operations | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Mr. John Terence RogersCFO & Executive Director | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Mr. Scott SchaffnerPresident of Sports Medicine | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Dr. Rohit KashyapPresident of Advanced Wound Management & Global Commercial Operations | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Dr. Vasant PadmanabhanPresident Research & Development, ENT and Emerging Markets | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Ms. Elga LohlerChief HR Officer | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Dr. Deepak S. NathCEO & Director | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Ms. Helen BarracloughGroup General Counsel & Company Secretary | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Ms. Alison ParkesCCO & Compliance APAC | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Dr. Ajay DhankharChief Corporate Development & Strategy Officer | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Mr. John Terence RogersCFO & Executive Director | 266,56k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Dr. Ajay DhankharChief Corporate Development & Strategy Officer | 152,76k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Mr. Craig GaffinPresident of Global Orthopaedics | 115,49k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Ms. Elga LohlerChief HR Officer | 102,51k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Mr. Paul ConnollyPresident of Global Operations | 77,97k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Dr. Rohit KashyapPresident of Advanced Wound Management & Global Commercial Operations | 167,34k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Dr. Vasant PadmanabhanPresident Research & Development, ENT and Emerging Markets | 99,09k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Mr. Mizanu KebedeChief Quality & Regulatory Affairs Officer | 75,21k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Ms. Alison ParkesCCO & Compliance APAC | 27,06k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Mr. Scott SchaffnerPresident of Sports Medicine | 172,02k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Dr. Deepak S. NathCEO & Director | 487,91k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Ms. Helen BarracloughGroup General Counsel & Company Secretary | 77,48k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-01-20 | Cevian Capital ABSociété | 4,92M | 80,44M | Achat | 15,84 - 16,53 | 81,69M | 6,41% |
| 2026-01-16 | Mr. Scott SchaffnerPresident of Sports Medicine | 242,59 | 6,28k | Acquisition Under Employee Benefit Plan | 25,90 | 1,67k | 17,02% |
| 2026-01-16 | Dr. Deepak S. NathCEO & Director | 410,11 | 10,62k | Acquisition Under Employee Benefit Plan | 25,90 | 5,08k | 8,77% |
| 2026-01-16 | Mr. Craig GaffinPresident of Global Orthopaedics | 206,80 | 5,36k | Acquisition Under Employee Benefit Plan | 25,90 | 305,00 | 210,58% |
| 2026-01-16 | Mr. Paul ConnollyPresident of Global Operations | 410,11 | 10,62k | Acquisition Under Employee Benefit Plan | 25,90 | 473,00 | 652,05% |
| 2025-11-11 | Mr. Scott SchaffnerPresident of Sports Medicine | 29,15 | 970,62 | Acquisition Under Employee Benefit Plan | 33,29 | 1,55k | 1,92% |
| 2025-11-11 | Dr. Deepak S. NathCEO & Director | 24,81 | 825,95 | Acquisition Under Employee Benefit Plan | 33,29 | 4,88k | 0,51% |
| 2025-11-11 | Mr. Craig GaffinPresident of Global Orthopaedics | 22,51 | 749,40 | Acquisition Under Employee Benefit Plan | 33,29 | 202,00 | 12,54% |
| 2025-11-11 | Mr. Mizanu KebedeChief Quality & Regulatory Affairs Officer | 12,03 | 400,62 | Acquisition Under Employee Benefit Plan | 33,29 | 431,00 | 2,87% |
| 2025-11-11 | Mr. Paul ConnollyPresident of Global Operations | 24,72 | 822,98 | Acquisition Under Employee Benefit Plan | 33,29 | 268,00 | 10,16% |
| 2025-11-11 | Dr. Deepak S. NathCEO & Director | 1,78k | 0,00 | Derivative Exercise and Retained Stock | - | 296,13k | 0,60% |
| 2025-11-11 | Dr. Deepak S. NathCEO & Director | -1,24k | 20,53k | Derivative Exercise and Sale | 16,56 | 296,13k | - |
| 2025-11-07 | Mr. Scott SchaffnerPresident of Sports Medicine | 746,79 | 12,20k | Acquisition Under Employee Benefit Plan | 16,33 | 71,26k | 1,06% |
| 2025-11-07 | Dr. Deepak S. NathCEO & Director | 2,62k | 42,86k | Acquisition Under Employee Benefit Plan | 16,33 | 294,35k | 0,90% |
| 2025-11-07 | Mr. Mizanu KebedeChief Quality & Regulatory Affairs Officer | 4,17 | 68,15 | Acquisition Under Employee Benefit Plan | 16,33 | 10,81k | 0,04% |
| 2025-11-07 | Mr. Paul ConnollyPresident of Global Operations | 394,42 | 6,44k | Acquisition Under Employee Benefit Plan | 16,33 | 36,81k | 1,08% |
| 2025-09-09 | Dr. Vasant PadmanabhanPresident Research & Development, ENT and Emerging Markets | -17,64k | 340,22k | Vente | 19,28 | 135,56k | -11,52% |
| 2025-08-27 | Dr. Ajay DhankharChief Corporate Development & Strategy Officer | 249,31k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-08-22 | Mr. Simon Jonathan LowthIndependent Non-Executive Director | 355,00 | 6,65k | Achat | 18,73 | 655,00 | 118,33% |
| 2025-08-22 | Ms. Angela Susan RisleyInitié | 373,00 | 6,98k | Achat | 18,71 | 6,35k | 6,24% |
| 2025-08-22 | Mr. Jeremy Kim MaidenIndependent Non-Executive Director | 353,00 | 6,59k | Achat | 18,66 | 3,50k | 11,21% |
| 2025-08-22 | Dr. Katarzyna Mazur-HofsaessIndependent Non-Executive Director | 541,00 | 10,14k | Achat | 18,74 | 2,37k | 29,56% |
| 2025-08-22 | Ms. Joanna Christine HallasIndependent Non-Executive Director | 389,00 | 7,29k | Achat | 18,73 | 6,58k | 6,28% |
| 2025-08-22 | Mr. Marc Ellis OwenIndependent Non-Executive Director | 202,00 | 7,52k | Achat | 37,25 | 0,00 | -100,00% |
| 2025-08-22 | Dr. Changzheng MaIndependent Non-Executive Director | 305,00 | 11,36k | Achat | 37,25 | 0,00 | -100,00% |
| 2025-08-20 | Ms. Sybella Jane StanleyIndependent Non-Executive Director | 1,52k | 28,48k | Achat | 18,73 | 5,33k | 39,90% |
| 2025-08-18 | Dr. Deepak S. NathCEO & Director | 25,83k | 0,00 | Derivative Exercise and Retained Stock | - | 291,73k | 9,72% |
| 2025-08-18 | Dr. Deepak S. NathCEO & Director | -18,01k | 328,90k | Derivative Exercise and Sale | 18,27 | 291,73k | - |
| 2025-08-06 | Ms. Elga LohlerChief HR Officer | -12,56k | 224,69k | Vente | 17,89 | 177,82k | -6,60% |
| 2025-07-09 | Mr. Scott SchaffnerPresident of Sports Medicine | 298,19 | 8,88k | Acquisition Under Employee Benefit Plan | 29,77 | 1,53k | 24,21% |
| 2025-07-09 | Dr. Deepak S. NathCEO & Director | 512,30 | 15,25k | Acquisition Under Employee Benefit Plan | 29,77 | 4,87k | 11,76% |
| 2025-07-09 | Mr. Craig GaffinPresident of Global Orthopaedics | 381,29 | 11,35k | Acquisition Under Employee Benefit Plan | 29,77 | 191,00 | -200,37% |
| 2025-07-09 | Mr. Mizanu KebedeChief Quality & Regulatory Affairs Officer | 114,62 | 3,41k | Acquisition Under Employee Benefit Plan | 29,77 | 425,00 | 36,93% |
| 2025-07-09 | Mr. Paul ConnollyPresident of Global Operations | 512,30 | 15,25k | Acquisition Under Employee Benefit Plan | 29,77 | 256,00 | -199,88% |
| 2025-05-14 | Cevian Capital ABSociété | 7,99M | 115,98M | Achat | 14,07 - 15,17 | 74,47M | 12,02% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
